AstraZeneca plc (AZN) Receives "Buy" Rating from Jefferies Group


's stock had its "buy" rating reiterated by Jefferies Group in a note issued to investors on Thursday, ARN reports. They currently have a GBX 5,600 target price on the biopharmaceutical company's stock.



from Biotech News